7 agosto 2015
Researchers have identified a novel genetic biomarker responsible for the progression of many breast and prostate cancers. The finding could bolster efforts to better identify patients who respond to certain types of chemotherapy drugs, they say.
http://www.sciencedaily.com/releases/2015/08/150807094643.htm
